Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Inv. presentation
Director departure
Appointed director

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/17/2023 4 Vogt Frederick G (Interim CEO & General Counsel) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Paid exercise price by delivering 8,851 shares @ $7.76, valued at $68.7k
Exercised 20,834 restricted stock units @ $0
07/17/2023 4 GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Paid exercise price by delivering 1,395 shares @ $7.76, valued at $10.8k
Exercised 2,813 restricted stock units @ $0
07/17/2023 4 BILINSKY IGOR (COO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Paid exercise price by delivering 1,395 shares @ $7.76, valued at $10.8k
Exercised 2,813 restricted stock units @ $0
06/08/2023 4 Countouriotis Athena (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Granted 51,955 options to buy @ $0
06/08/2023 4 MCPEAK MERRILL A (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Granted 51,955 options to buy @ $0
06/08/2023 4 Maynard Ryan D (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Granted 51,955 options to buy @ $0
06/08/2023 4 WEISER MICHAEL (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Granted 51,955 options to buy @ $0
06/08/2023 4 Dukes Iain D. (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Granted 103,911 options to buy @ $0
06/08/2023 4 YARNO WENDY L (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Granted 12,988 options to buy @ $0
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
04/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/06/2023 4 Vogt Frederick G (See Remarks) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Granted 125,000 restricted stock units @ $0
Granted 500,000 options to buy @ $7.12, valued at $3.6M
03/06/2023 4 GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Granted 46,875 restricted stock units @ $0
Granted 93,750 options to buy @ $7.12, valued at $667.5k
03/06/2023 4 BILINSKY IGOR (COO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Granted 42,190 restricted stock units @ $0
Granted 84,380 options to buy @ $7.12, valued at $600.8k
03/06/2023 4 Bellemin Jean-Marc (CFO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Granted 168,750 options to buy @ $7.12, valued at $1.2M
01/19/2023 4 GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Paid exercise price by delivering 4,678 shares @ $6.43, valued at $30.1k
Exercised 11,248 restricted stock units @ $0
01/19/2023 4 BILINSKY IGOR (COO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Paid exercise price by delivering 4,671 shares @ $6.43, valued at $30k
Exercised 11,248 restricted stock units @ $0
01/19/2023 4 Vogt Frederick G (Interim CEO & General Counsel) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Paid exercise price by delivering 36,441 shares @ $6.43, valued at $234.3k
Exercised 83,325 restricted stock units @ $0
01/05/2023 4 GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Paid exercise price by delivering 11,023 shares @ $6.11, valued at $67.4k
Exercised 19,690 restricted stock units @ $0
01/05/2023 4 BILINSKY IGOR (COO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Paid exercise price by delivering 10,553 shares @ $6.11, valued at $64.5k
Exercised 18,850 restricted stock units @ $0
01/05/2023 4 Bellemin Jean-Marc (CFO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Paid exercise price by delivering 10,553 shares @ $6.11, valued at $64.5k
Exercised 18,850 restricted stock units @ $0
12/22/2022 4 MCPEAK MERRILL A (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Bought 10,000 shares @ $6.15, valued at $61.5k
12/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/30/2022 4 MCPEAK MERRILL A (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Bought 10,000 shares @ $6.31, valued at $63.1k
11/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/28/2022 4 MCPEAK MERRILL A (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Bought 10,000 shares @ $6.18, valued at $61.8k
11/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/25/2022 4 MCPEAK MERRILL A (Director) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Exercised 40,000 options to buy @ $5.65, valued at $226k
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Bellemin Jean-Marc (CFO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Exercised 18,850 shares @ $0
Paid exercise price by delivering 9,346 shares @ $7.73, valued at $72.2k
Granted 18,850 options to buy @ $0
06/16/2022 4 BILINSKY IGOR (COO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.
Txns: Exercised 18,850 shares @ $0
Paid exercise price by delivering 9,346 shares @ $7.73, valued at $72.2k
Granted 18,850 options to buy @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy